Ultra rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate

Clinical and Experimental Allergy

Volumn 25, Issue 12, 1995, Pages 1205-1210

  Jutel, M ^a   Skrbic, D ^a   Pichler, W J ^a   Muller, U R ^a  

^a Spital Netz Bern   (Switzerland)

Author keywords

Bee venom; Hymenoptera venom allergy; Insect sting allergy; Mast cells; Rush immunotherapy; Skin testing

Indexed keywords

BEE VENOM; CODEINE PHOSPHATE; IMMUNOGLOBULIN E; VENOM ANTISERUM;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; IMMUNOTHERAPY; INSECT ALLERGY; INTRADERMAL DRUG ADMINISTRATION; MAST CELL; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; SKIN TEST;

EID: 0029610595     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1995.tb03044.x     Document Type: Article

References (19)

1. 1 Lichtenstein LM, Valentine MD. Sobotka AK. A case for venom treatment in anaphylactic sensitivity to hymen‐optcra sting. N Engl J Med 1974 ; 290: 1223–7.
2. 2 Hunt KJ, Valentine MD. Sobotka et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med. 1978 ; 299: 157–61.
3. 3 Müller U. Thurnheer U. Patrizzi R, Spicss J, Hoigne R. Immunotherapy in bee sting hypersensilivity. Bee venom versus whole body extract. Allergy 1979 ; 34: 369–78.
4. 4 Van De Zwau JC, Flinterman J. Jankowski IG, Kerchaert JAM. Hyposensitisation to wasp venoms in six hours. Br Med J 1983: 287: 1329–31.
5. 5 Bernstein DI, Mittman RJ, Kagen SL et al. Clinical and immunologic studies of rapid venom immunotherapy in hymenoptera sensitive patients. J All Clin Immunol 1989: 84: 951–9.
6. 6 Birnbaum J. Charpin D, Vervloet D. Rapid hymenoptera venom immunotherapy: comparative safely of three protocols. Clin Exp Allergy 1993: 23: 226–30.
7. 7 Skrbic D. Ultrarush‐Hyposcnsibilisierung mit Hymen‐oplerengiften. Thesis. Bern, 1994.
8. 8 Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966: 3: 331–3.
9. 9 Müller U. Insect sting allergy. Clinical picture, diagnosis and treatment Stuttgart: Fisher, 1990: 50–67.
10. 10 Berlhcr T, Conroy MC. DcWeck AL. Urticarial skin reaction lo codein, a measure of mast cell reactivity. Schweiz Med Wochenschr. 1980 ; 110: 758–63.
11. 11 Thurnheer U, Müller U, Stollor R, Lanner A. Hoigne R. Venom immunotherapy in Hymenoptera sting allergy. Allergy 1983: 38: 465–75.
12. 12 Sachs L. Angewandte Statistic. Berlin, Heidelberg: Springer Verlag, 1978.
13. 13 Turkeltaub P, Rastogi S, Baer H, Anderson M, Norman P. A stantlardized quantitative skin lest assay of allergen potency and stability. J Allergy Clin Immunol 1982 ; 70: 343–52.
14. 14 Lichtenstein LM, Sobotka AK. Immunotherapy for insecl sling allergy. ACI News 1989 ; 1/2: 39–42.
15. 15 Müller U, Helbling A, Bischof M. Predictive value of venom specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venorn. Allergy 1989 ; 44: 412–8.
16. 16 Jutel M, Pichler W, Skrbic D et al. Bee venom immunotherapy decreases IL‐4 and IL‐5 and increases IFN‐γ secretion in specific allergen stimulated T‐cell cultures. J Immunology 1995 ; 154: 4187–94.
17. 17 Tsicopoulos A, Tonnel A, Wallaerl B et al. Short‐term decrease in skin‐sensitivity after rush hyposensitization in Hymenoptera venom hypersensilivity. Clin Exp Allergy 1990 ; 20: 289–94.
18. 18 Müller U. Helbling A, Bcrchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992 ; 89: 529–35.
19. 19 Stcphan V, Kühr J, Urbanek R. Relevance of basophil histamine release changes during venom immunotherapy. Allergy 1989 ; 44: 453–59.